Ö. G. SEVİNDİK Et Al. , "HYPOALBUMINEMIA IS A SURROGATE BIOMARKER OF POOR PROGNOSIS IN MYELODYSPLASTIC SYNDROME EVEN WHEN ADJUSTED WITH COMORBIDITIES," THE 13TH INTERNATIONAL SYMPOSIUM ON MYELODYSPLASTIC SYNDROMES , vol.39, Washington, Kiribati, pp.123, 2015
SEVİNDİK, Ö. G. Et Al. 2015. HYPOALBUMINEMIA IS A SURROGATE BIOMARKER OF POOR PROGNOSIS IN MYELODYSPLASTIC SYNDROME EVEN WHEN ADJUSTED WITH COMORBIDITIES. THE 13TH INTERNATIONAL SYMPOSIUM ON MYELODYSPLASTIC SYNDROMES , (Washington, Kiribati), 123.
SEVİNDİK, Ö. G., GÜÇ, Z., KAHRAMAN, S., SOLMAZ MEDENİ, Ş., KATGI, A., ACAR, C., ... ALACACIOĞLU, İ.(2015). HYPOALBUMINEMIA IS A SURROGATE BIOMARKER OF POOR PROGNOSIS IN MYELODYSPLASTIC SYNDROME EVEN WHEN ADJUSTED WITH COMORBIDITIES . THE 13TH INTERNATIONAL SYMPOSIUM ON MYELODYSPLASTIC SYNDROMES (pp.123). Washington, Kiribati
SEVİNDİK, Ömür Et Al. "HYPOALBUMINEMIA IS A SURROGATE BIOMARKER OF POOR PROGNOSIS IN MYELODYSPLASTIC SYNDROME EVEN WHEN ADJUSTED WITH COMORBIDITIES," THE 13TH INTERNATIONAL SYMPOSIUM ON MYELODYSPLASTIC SYNDROMES, Washington, Kiribati, 2015
SEVİNDİK, Ömür G. Et Al. "HYPOALBUMINEMIA IS A SURROGATE BIOMARKER OF POOR PROGNOSIS IN MYELODYSPLASTIC SYNDROME EVEN WHEN ADJUSTED WITH COMORBIDITIES." THE 13TH INTERNATIONAL SYMPOSIUM ON MYELODYSPLASTIC SYNDROMES , Washington, Kiribati, pp.123, 2015
SEVİNDİK, Ö. G. Et Al. (2015) . "HYPOALBUMINEMIA IS A SURROGATE BIOMARKER OF POOR PROGNOSIS IN MYELODYSPLASTIC SYNDROME EVEN WHEN ADJUSTED WITH COMORBIDITIES." THE 13TH INTERNATIONAL SYMPOSIUM ON MYELODYSPLASTIC SYNDROMES , Washington, Kiribati, p.123.
@conferencepaper{conferencepaper, author={Ömür Gökmen SEVİNDİK Et Al. }, title={HYPOALBUMINEMIA IS A SURROGATE BIOMARKER OF POOR PROGNOSIS IN MYELODYSPLASTIC SYNDROME EVEN WHEN ADJUSTED WITH COMORBIDITIES}, congress name={THE 13TH INTERNATIONAL SYMPOSIUM ON MYELODYSPLASTIC SYNDROMES}, city={Washington}, country={Kiribati}, year={2015}, pages={123} }